Inogen Inc awarded CEO and President Kevin Raymond Merrill 1,500 shares at $5.33 per share on Sep 1, 2026. The post-transaction ownership figure was 134,962 shares, giving investors a stated reference for Merrill’s Inogen share position after the award in the record.
Key Highlights
- Kevin Raymond Merrill was identified as Inogen’s CEO and President.
- The award was recorded on Sep 1, 2026.
- The transaction carried code A and left Merrill with 134,962 Inogen shares.
Inogen Inc (NASDAQ: INGN) awarded CEO and President Kevin Raymond Merrill 1,500 shares at $5.33 per share. Merrill’s reported ownership after the transaction was 134,962 Inogen shares.
Executive Award Recorded on Sep 1
The award was recorded on Sep 1, 2026, under transaction code A. Merrill was identified in the transaction record as both Inogen’s CEO and President. The securities involved were Inogen shares, with the stated price set at $5.33 per share. The post-transaction ownership figure was 134,962 shares. That total is the ownership position stated for Merrill after the award. The reported figures identify both the size of the award and the per-share price attached to it.
FAQs
Q: How many Inogen shares did Kevin Raymond Merrill receive?
A: Inogen CEO and President Kevin Raymond Merrill received 1,500 Inogen shares. The stated award price was $5.33 per share in the reported transaction.
Q: What was Merrill’s Inogen ownership after the stock award?
A: Merrill’s reported post-transaction ownership was 134,962 Inogen shares. That figure reflects his position after the 1,500-share award identified in the filing.
Q: When was the Inogen CEO stock award recorded?
A: The Inogen stock award was recorded on Sep 1, 2026. The transaction carried code A and involved shares priced at $5.33 per share.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.